Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Modeling Zika virus transmission from mother to child using uterine mini-organs
As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...
Can we make anesthesia for dogs safer with the help of nutrition?
Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...
The Dogs of Chernobyl Research Initiative
The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...